Literature DB >> 32679022

Developments in the Application of 1,2,3-Triazoles in Cancer Treatment.

Katerina I Slavova1, Lozan T Todorov1, Nataliya P Belskaya2, Mauricio A Palafox3, Irena P Kostova1.   

Abstract

BACKGROUND: The impact of cancer on modern society cannot be emphasized enough in terms of both economic and human costs. Cancer treatments are known, unfortunately, for their side effects - frequently numerous and severe. Drug resistance is another issue medical professionals have to tackle when dealing with neoplastic illnesses. Cancer rates are rising worldwide due to various factors - low-quality nutrition, air and water pollution, tobacco use, etc. For those and many other reasons, drug discovery in the field of oncology is a top priority in modern medical science.
OBJECTIVE: To present the reader with the latest in cancer drug discovery with regard to 1,2,3-triazole- containing molecules in a clear, concise way so as to make the present review a useful tool for researchers.
METHODS: Available information present on the role of 1,2,3-triazoles in cancer treatment was collected. Data was collected from scientific literature, as well as from patents.
RESULTS: A vast number of triazole-containing molecules with antiproliferative properties have been proposed, synthesized and tested for anticancer activity both in vitro and in vivo. The substances vary greatly when considering molecular structure, proposed mechanisms of action and affected cancer cell types.
CONCLUSION: Triazole-containing molecules with anticancer activity are being widely synthesized and extensively tested. They vary significantly in terms of both structure and mechanism of action. The methods for their preparation and administration are well established and with proven reproducibility. These facts suggest that triazoles may play an important role in the discovery of novel antiproliferative medications with improved effectiveness and safety profile. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  1; 2; 3-triazoles; Antiproliferative; cancer; cell lines; in vitro; in vivo; patents; therapy

Mesh:

Substances:

Year:  2020        PMID: 32679022     DOI: 10.2174/1574892815666200717164457

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  5 in total

1.  Novel Dihydropyrimidinone Derivatives as Potential P-Glycoprotein Modulators.

Authors:  Sabera Bijani; Faraz Shaikh; Sheefa Mirza; Shirley Weng In Siu; Nayan Jain; Rakesh Rawal; Nigel G J Richards; Anamik Shah; Ashish Radadiya
Journal:  ACS Omega       Date:  2022-05-02

2.  Urea-thiazole/benzothiazole hybrids with a triazole linker: synthesis, antimicrobial potential, pharmacokinetic profile and in silico mechanistic studies.

Authors:  Nisha Poonia; Kashmiri Lal; Ashwani Kumar; Anil Kumar; Srikanta Sahu; Anurag T K Baidya; Rajnish Kumar
Journal:  Mol Divers       Date:  2021-10-20       Impact factor: 3.364

3.  MOF-Derived Cu@N-C Catalyst for 1,3-Dipolar Cycloaddition Reaction.

Authors:  Zhuangzhuang Wang; Xuehao Zhou; Shaofeng Gong; Jianwei Xie
Journal:  Nanomaterials (Basel)       Date:  2022-03-24       Impact factor: 5.076

4.  The straightforward synthesis of N-coordinated ruthenium 4-aryl-1,2,3-triazolato complexes by [3 + 2] cycloaddition reactions of a ruthenium azido complex with terminal phenylacetylenes and non-covalent aromatic interactions in structures.

Authors:  Chao-Wan Chang; Chi-Rung Lee; Gene-Hsiang Lee; Kuang-Lieh Lu
Journal:  RSC Adv       Date:  2022-08-31       Impact factor: 4.036

Review 5.  1,2,3-Triazole-Containing Compounds as Anti-Lung Cancer Agents: Current Developments, Mechanisms of Action, and Structure-Activity Relationship.

Authors:  Ting Liang; Xiangyang Sun; Wenhong Li; Guihua Hou; Feng Gao
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.